This is a rare genetic condition. It affects how your body makes heme, a part of red blood cells. The problem is a missing enzyme called ferrochelatase. This causes a buildup of a substance called protoporphyrin in your body. It mainly causes nerve problems, but sometimes skin issues too. It's inherited, meaning you get it from your parents.
Every report comes from a Lived member, sent anonymously.
Have you tried beta Carotene for Erythropoietic Protoporphyria?
Erythropoietic protoporphyria (EPP) is a rare inherited condition that makes the skin painfully sensitive to light. Within minutes of sun exposure, people typically feel tingling, burning or itching, most often on the face and the backs of the hands. These early sensations are a warning: if exposure continues, they can turn into severe, deep pain, sometimes with redness and swelling. Unlike a sunburn, the skin usually does not blister or scar, and the pain responds poorly to ordinary painkillers. It can take several days to settle. The cause is a substance called protoporphyrin, a building block the body uses to make heme, the iron-containing part of hemoglobin in red blood cells. In EPP, protoporphyrin builds up in the blood and skin, where light (especially blue visible light, which ordinary window glass does not fully block) activates it and inflames nearby tissue. Some of the excess also passes through the liver into bile, so EPP can affect the liver and gallbladder too. Symptoms usually start in early childhood. Because the skin often looks nearly normal afterward, children can be dismissed as fussy or overreacting, and diagnosis is often delayed by many years. A closely related condition, X-linked protoporphyria, causes the same symptoms through a different gene and is managed the same way.
EPP is genetic. It results from too little ferrochelatase, the enzyme that completes the final step of heme production. Most people with EPP inherit two different changes in the gene that carries the instructions for ferrochelatase (called FECH), one from each parent: a serious variant that stops one copy from working, and a common weaker variant that lowers enzyme output from the other copy. The weaker variant is carried by up to about 1 in 10 white people and causes no problems on its own. EPP appears only when the two are combined, which is why it can show up in a family with no known history. X-linked protoporphyria comes from a change in a different gene (ALAS2) on the X chromosome. Males are usually affected, while females range from no symptoms to symptoms as severe as in males. Very rarely, EPP first appears in an older adult because of a bone marrow disorder rather than inheritance. Light is the trigger for symptoms, not the cause. Sunlight is the main trigger, and some people also react to certain artificial light, such as fluorescent lighting. Alcohol does not cause EPP, but heavy drinking adds strain on a liver already handling extra protoporphyrin.
The key test is a blood test that measures protoporphyrin inside red blood cells. In EPP the level is high, and most of it is in a metal-free form rather than bound to zinc. The ratio between the two forms helps distinguish EPP from X-linked protoporphyria and from other causes of a raised level, such as iron deficiency. Urine porphyrin tests, used for some other porphyrias, miss EPP because protoporphyrin does not dissolve in water. Genetic testing then confirms the type and shows how it was inherited, which matters for family planning and may help estimate liver risk. Genetic testing alone, without the blood test, is not recommended. At diagnosis, clinicians also check liver tests, a blood count, iron levels and vitamin D, since each can be affected.
There is no cure, but treatment can widen how much light a person tolerates and protect long-term health. The foundation is light protection: planning time outdoors, tightly woven or opaque clothing, gloves, wide-brimmed hats and tinted film on car and home windows. Ordinary clear sunscreens do not help, because they block ultraviolet light rather than the visible light that triggers EPP. Some people get a small benefit from tinted mineral sunscreens containing zinc oxide or titanium dioxide. For adults, afamelanotide (Scenesse) is the only medicine approved by the US Food and Drug Administration. It is a small implant placed under the skin of the hip by a trained clinician every 2 months. It mimics a natural hormone that darkens the skin, and in studies it increased the time people could spend in light without pain and improved quality of life. It does not replace light protection. It darkens the skin overall and can darken existing moles and freckles, so a full skin check with a dermatologist is advised every 6 months. Nausea and reactions where the implant is placed are common. Access in the US is limited by cost and the small number of treatment sites, and there is no safety data in pregnancy. No medicine is approved for children, and other medicines are being studied in clinical trials. Beta-carotene was used for decades, but good evidence shows little or no benefit. During a reaction, cool water or cold compresses may give some relief, while common pain relievers, steroids and antihistamines have not been shown to help. Other care protects the rest of the body: vitamin D supplements, iron when deficiency is causing symptoms, hepatitis A and B vaccines, and avoiding heavy alcohol use. People with serious liver disease need a specialist team, and in the rare cases of liver failure, a liver transplant can be lifesaving, sometimes followed by a bone marrow transplant to stop the disease damaging the new liver.
EPP is a lifelong condition. The daily burden comes less from visible skin damage than from pain and the constant planning to avoid it. Many people shape school, work, holidays and social life around daylight, and children may miss outdoor play or sports. School or workplace accommodations, explaining the condition to teachers and connecting with patient groups can make this easier. Sensitivity can vary with season, weather and from person to person: some react within minutes, others tolerate longer exposure. Most people do not develop serious complications, but follow-up matters because some do. Gallstones are common, affecting roughly a quarter of people with protoporphyria. Mild anemia and low vitamin D are frequent. About 1 to 5 in 100 people develop serious liver damage from protoporphyrin buildup, which can progress quickly. Higher protoporphyrin levels and X-linked protoporphyria in males raise that risk. For this reason, guidelines recommend liver tests, a blood count, iron and vitamin D checks at least once a year, along with protoporphyrin levels. Pregnancy outcomes in EPP are similar to those of the general population, and no extra light precautions are needed during pregnancy. Short procedures and endoscopy need no special lighting, but long operations such as a liver transplant need filters on the operating lights to prevent light injury to exposed tissue, so tell any surgical team about EPP in advance.
See a clinician, ideally a dermatologist or porphyria specialist, if you or your child repeatedly feel burning or pain after time in daylight, even when the skin looks normal, or if you have EPP and are not getting yearly blood and liver tests. Contact your care team promptly if you notice yellowing of the skin or the whites of the eyes, because it can signal protoporphyrin-related liver damage, which needs urgent specialist assessment. Also follow up quickly if a routine test shows rising liver enzymes.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Erythropoietic Protoporphyria is like, what's helped you, or ask the community a question.